Your session is about to expire
← Back to Search
Behavioral Science Methods for Child Health Education
N/A
Recruiting
Led By Susan Persky, Ph.D.
Research Sponsored by National Human Genome Research Institute (NHGRI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants in the main trial will be healthy adult parents 18 years and older
Participants in the Pilot test will be healthy adult parents 18 years and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at lab visit
Awards & highlights
Study Summary
This trial is testing new behavioral science methods and measures. Eligible participants are parents of children 3-7 years old. There are four tasks involved in the study.
Who is the study for?
This trial is for healthy adult parents, both fathers and mothers, who can read and write in English. They should have children aged between 3-7 years without major allergies or dietary-related health conditions and be able to visit the NIH Clinical Center once.Check my eligibility
What is being tested?
The study tests new behavioral science methods by having participants complete tasks like answering questions online about child health, watching a movie scene, reading information on child health topics, and making virtual food choices for their child.See study design
What are the potential side effects?
Since this is a behavioral study involving information provision and emotion induction through various tasks rather than medical interventions, there are no direct physical side effects expected from participation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a healthy adult parent aged 18 or older.
Select...
I am a healthy adult parent aged 18 or older.
Select...
I am a healthy adult aged 18 to 59.
Select...
I can visit the clinic once.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at lab visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at lab visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Exhibited emotion, Feeding decisions, self-reported attitudes, beliefs and intentions; perceptual responses
Trial Design
7Treatment groups
Experimental Treatment
Group I: 4Experimental Treatment2 Interventions
Loss frame; Fear
Group II: 3bExperimental Treatment1 Intervention
low visual perceptual load
Group III: 3Experimental Treatment2 Interventions
Loss frame; Anger
Group IV: 2bExperimental Treatment1 Intervention
high visual perceptual load
Group V: 2Experimental Treatment2 Interventions
Gain frame; Fear
Group VI: 1bExperimental Treatment1 Intervention
high visual perceptual load high interactive
Group VII: 1Experimental Treatment2 Interventions
Gain frame; Anger
Find a Location
Who is running the clinical trial?
National Human Genome Research Institute (NHGRI)Lead Sponsor
263 Previous Clinical Trials
283,462 Total Patients Enrolled
Susan Persky, Ph.D.Principal InvestigatorNational Human Genome Research Institute (NHGRI)
6 Previous Clinical Trials
3,702 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent of a healthy child aged 3-7 with no major allergies or health issues.I can visit the NIH Clinical Center for one appointment.I have difficulty moving around freely.I am a healthy adult parent aged 18 or older.I am a healthy adult parent aged 18 or older.I am a healthy adult parent aged 18 or older.I am a healthy adult aged 18 to 59.I can visit the clinic once.I am a parent of a healthy child aged 4-7 with no major allergies or diet issues.I have poor vision and hearing that hasn't been corrected.I have epilepsy or a seizure disorder.I am a parent of a young child with no major allergies or health issues.I am 59 years old or younger.
Research Study Groups:
This trial has the following groups:- Group 1: 2
- Group 2: 2b
- Group 3: 3
- Group 4: 4
- Group 5: 3b
- Group 6: 1b
- Group 7: 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the aggregate participant count of this clinical examination?
"Affirmative. Contextual information stored on clinicaltrials.gov affirms that this experiment is inviting participants; it was initially posted on January 15th 2016 and most recently updated November 11 2022, seeking 670 enrollees across two sites."
Answered by AI
Are participants still being sought for this investigation?
"According to clinicaltrials.gov, this investigation is still accepting participants as of November 11th 2022. The trial was initiated on January 15th 2016 and has been frequently updated since then."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger